The Hypotensive Effects of Home-Based Isometric Handgrip Training in Older Adults With Pre-Hypertension and Hypertension - The HoldAge Trial

May 19, 2023 updated by: Alberto Alves, University Institute of Maia
New data suggests that isometric handgrip training (IHT) might become a novel tool in the treatment of hypertension. The main purpose of this research project is to evaluate the effects of home-based IHT on ambulatory blood pressure in older adults with pre-hypertension and hypertension. Eighty-four older adults with pre-hypertension and hypertension will be randomly distributed to one of three groups: home-based IHT, home-based aerobic exercise training (AET), or attention-control group (CON). Each intervention will have a total duration of 8 weeks. At baseline and after completing the intervention, patients will undergo the following evaluations: 24-hour ambulatory blood pressure, cardiorespiratory fitness, endothelial function, damage and repair, arterial stiffness, inflammatory biomarkers, autonomic function, physical activity levels, dietary intake and quality of life. A qualitative analysis will also be applied to enhance the understanding of the efficacy of this intervention from the patient's perspective.

Study Overview

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aveiro, Portugal, 3810-193
        • University of Aveiro
      • Aveiro, Portugal, 3810-096
        • Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
      • Aveiro, Portugal, 3810-193
        • Institute of Biomedicine
      • Guimarães, Portugal, 4765-546
        • Unidade de Saúde Familiar Serzedelo
      • Porto, Portugal, 4200-450
        • CINTESIS, Faculty of Medicine, Porto, Portugal
      • Vila Real, Portugal, 5001-801
        • Reserach Center in Sports Sciences, Health Sciences and Human Development
    • Aveiro
      • Santa Joana, Aveiro, Aveiro, Portugal, 3810-164
        • Unidade de Saúde Familiar de Santa Joana
    • Porto
      • Maia, Porto, Portugal, 4475-690
        • University Institute of Maia
      • Matosinhos, Porto, Portugal, 4450-113
        • Hypertension Unit, Hospital Pedro Hispano, ULS, Matosinhos, Portugal
    • Connecticut
      • Storrs, Connecticut, United States, 06269
        • University of Connecticut

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • Secondary Hypertension
  • Target Organ Damage
  • Coronary Artery Disease
  • Heart Failure
  • Any Previous Cardiovascular Event
  • Peripheral Artery Disease
  • Renal Failure
  • Chronic Obstructive Pulmonary Disease
  • Insulin Dependent Diabetes
  • Change of Antihypertensive Medication in the Past 4 Weeks Before Inclusion in the Study
  • Smokers
  • Those Participating in Regular Physical Activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Isometric Handgrip Training
The 8-week exercise program will include three sessions of isometric handgrip training per week
The 8-week exercise program will include three sessions of isometric handgrip training per week
Active Comparator: Aerobic Exercise Training
The 8-week exercise program will include three sessions of aerobic exercise per week
The 8-week exercise program will include three sessions of aerobic exercise per week
No Intervention: Control Group
The control group will receive usual medical care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
24h ambulatory blood pressure
Time Frame: Change from baseline to 2 months
Change from baseline to 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial Stiffness
Time Frame: Change from baseline to 2 months
Assessed by application tonometry using carotid-femoral pulse wave velocity as the gold-standard measure
Change from baseline to 2 months
Endothelial function
Time Frame: Change from baseline to 2 months
Assessed by brachial artery dilation to endothelial-dependent stimuli using an ultrasound, according to the recommendations
Change from baseline to 2 months
Inflamamtion
Time Frame: Change from baseline to 2 months
Plasma levels of inflammatory and anti-inflammatory biomarkers including C-reactive protein, Interleukin-10, total nitric oxide and nitrate/nitrite, endothelial Nitric Oxide Synthase
Change from baseline to 2 months
Endothelial cell repair/damage
Time Frame: Change from baseline to 2 months
Assessed by the circulating number of endothelial progenitor cells and circulating endothelial cells in a peripheral blood by flow cytometry.
Change from baseline to 2 months
Health-related quality of life
Time Frame: Change from baseline to 2 months
Assessed by the Short-Form 36
Change from baseline to 2 months
Aerobic fitness
Time Frame: Change from baseline to 2 months
Assessed by Chester Step Test
Change from baseline to 2 months
Weekly physical activity sleep quality
Time Frame: Change from baseline to 2 months
Measured in seven consecutive days by accelerometry
Change from baseline to 2 months
Intervention quality
Time Frame: two weeks after the intervention
Assessed by focus group interviews using semi-structured guide with the participants of the experimental groups
two weeks after the intervention
Sleep quality
Time Frame: Change from baseline to 2 months
Measured in seven consecutive days by accelerometry
Change from baseline to 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2021

Primary Completion (Actual)

January 30, 2023

Study Completion (Actual)

January 30, 2023

Study Registration Dates

First Submitted

February 10, 2020

First Submitted That Met QC Criteria

February 14, 2020

First Posted (Actual)

February 19, 2020

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • POCI-01-0145-FEDER-030646

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Isometric Handgrip Training

Subscribe